Kithsiri Herath Selected Research

platensimycin

1/2017	Correction: The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys.
1/2016	The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys.
5/2006	Platensimycin is a selective FabF inhibitor with potent antibiotic properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kithsiri Herath Research Topics

Disease

5	Dyslipidemias (Dyslipidemia) 01/2018 - 06/2012
4	Insulin Resistance 01/2018 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 12/2016 - 10/2013
2	Fatty Liver 01/2017 - 01/2016
2	Bacterial Infections (Bacterial Infection) 03/2012 - 05/2006
1	Renal Insufficiency (Renal Failure) 04/2021
1	Body Weight (Weight, Body) 01/2018
1	Hyperglycemia 11/2015
1	Diabetes Mellitus 10/2013
1	Infections 05/2009
1	Staphylococcal Infections 05/2006

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2013
3	platensimycinIBA 01/2017 - 05/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2012 - 05/2006
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2017 - 01/2016
2	Glucagon (Glukagon)FDA Link 11/2015 - 10/2013
1	Glycerol (Glycerine)FDA LinkGeneric 04/2021
1	FructosuriaIBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	FructoseIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2017
1	SREBP cleavage-activating proteinIBA 01/2017
1	Insulin (Novolin)FDA Link 12/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	N- ((4- (1- (3- (3,5- dichlorophenyl)- 5- (6- methoxynaphthalen- 2- yl)- 1H- pyrazol- 1- yl)ethyl)phenyl)carbonyl)- beta- alanineIBA 11/2015
1	LipidsIBA 03/2014
1	Glucagon Receptors (Glucagon Receptor)IBA 10/2013
1	ApoproteinsIBA 06/2012
1	Lipoproteins (Lipoprotein)IBA 06/2012
1	Pharmaceutical PreparationsIBA 03/2012
1	Peptides (Polypeptides)IBA 05/2009
1	thiazomycinIBA 05/2009
1	thiazomycin AIBA 05/2009

Therapy/Procedure

1	Therapeutics 01/2017
1	Glycemic Control 12/2016
1	Intraperitoneal Injections 12/2016
1	Oral Administration 01/2016